At a glance
ClinicalIndex Comparison RecordN/ACompleted· 50 enrolled
Drug / intervention
Citalopram hydrobromide +2 moredrug
Likely dose
Citalopram hydrobromide 60 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Personalizing Treatment of Depression Complicated by Panic Features-Pilot Study
In Brief
A clinical study evaluating Interpersonal Psychotherapy for Depression with Panic and Anxiety Symptoms (IPT-PS), Brief Supportive Psychotherapy (BSP), and 1 other intervention for Depression and Anxiety. Completed, enrolled 50 participants across 1 site.
Detailed Summary
This study will examine the feasibility and efficacy of a personalized psychotherapy treatment for people with depression and co-occurring anxiety.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDepression, Anxiety
CountriesUnited States
CollaboratorsNational Institute of Mental Health (NIMH)
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedJun 2009
Enrollment StartJul 2009
Primary CompletionJun 2012
TodayJul 2026
First PostedJun 30, 2009
Enrollment StartJul 1, 2009
Primary CompletionJun 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 17.0 years ago
Interventions
Interpersonal Psychotherapy for Depression with Panic and Anxiety Symptoms (IPT-PS)behavioral
16 weekly IPT-PS sessions, each lasting approximately 45 minutes
Brief Supportive Psychotherapy (BSP)behavioral
16 weekly BPS sessions, each lasting approximately 45 minutes
Citalopram hydrobromidedrug
A 20-week regimen of citalopram hydrobromide monotherapy on a flexible dosing schedule ranging from 10 to 60 mg/day